SciVision Biotech Inc Cash Flow-to-Debt Ratio
SciVision Biotech Inc cash flow-to-debt ratio. SciVision Biotech Inc (1786) has a Cash Flow-to-Debt Ratio of 0.05x as of March 2026, meaning its operating cash flow of NT$48.51 Million could theoretically repay 0% of its total liabilities (NT$892.04 Million) in one year. Check 1786 cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of SciVision Biotech Inc (2009–2025)
Cash flow-to-debt ratio of SciVision Biotech Inc from 2009 to 2025. Historical debt coverage capacity for SciVision Biotech Inc across 17 annual periods. Check SciVision Biotech Inc investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
SciVision Biotech Inc Cash Flow-to-Debt Ratio by Year (2009–2025)
SciVision Biotech Inc cash flow-to-debt ratio by year from 2009 to 2025. Year-by-year debt coverage analysis for SciVision Biotech Inc. For the full cash flow conversion analysis, see 1786 cash flow metrics.
| Year | CF-to-Debt Ratio | Operating CF (TWD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.18x | NT$123.99 Million | NT$689.35 Million | ▼ -69.5% |
| 2024 | 0.59x | NT$269.87 Million | NT$457.43 Million | ▲ +15.7% |
| 2023 | 0.51x | NT$272.01 Million | NT$533.66 Million | ▲ +68.0% |
| 2022 | 0.30x | NT$178.21 Million | NT$587.30 Million | ▲ +150.1% |
| 2021 | 0.12x | NT$98.51 Million | NT$812.06 Million | ▼ -53.3% |
| 2020 | 0.26x | NT$126.47 Million | NT$486.55 Million | ▼ -36.3% |
| 2019 | 0.41x | NT$204.40 Million | NT$501.08 Million | ▲ +125.6% |
| 2018 | 0.18x | NT$111.70 Million | NT$617.70 Million | ▲ +634.2% |
| 2017 | 0.02x | NT$15.98 Million | NT$648.72 Million | ▼ -70.2% |
| 2016 | 0.08x | NT$38.29 Million | NT$462.93 Million | ▼ -79.4% |
| 2015 | 0.40x | NT$49.81 Million | NT$124.16 Million | ▲ +1390.5% |
| 2014 | 0.03x | NT$1.85 Million | NT$68.81 Million | ▼ -96.7% |
| 2013 | 0.82x | NT$37.27 Million | NT$45.23 Million | ▼ -8.3% |
| 2012 | 0.90x | NT$51.52 Million | NT$57.31 Million | ▼ -2.7% |
| 2011 | 0.92x | NT$37.13 Million | NT$40.17 Million | ▲ +1401.7% |
| 2010 | 0.06x | NT$6.85 Million | NT$111.24 Million | ▲ +117.8% |
| 2009 | -0.35x | NT$-36.09 Million | NT$104.31 Million | — |